The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal for ImmunoTherapy of Cancer
(Nov 2021)
856 INBRX-106: a novel hexavalent anti-OX40 agonist for the treatment of solid tumors
Quinn Deveraux,
Heather Kinkead,
Kyle Jones,
Bryan Becklund,
Florian Sulzmaier,
John Timmer,
Brendan Eckelman,
Analeah Heidt,
William Crago,
Emily Rowell,
Elisabeth Torretti
Affiliations
Quinn Deveraux
Aff653 grid.428605.dFive Prime Therapeutics South San Francisco CA USA
Heather Kinkead
Aff1 grid.21107.350000000121719311OncologyJohns Hopkins University Baltimore MD USA
Kyle Jones
2 Research Department of Infection and Population Health, University College London, London, UK
Bryan Becklund
Inhibrx, La Jolla, CA, United States
Florian Sulzmaier
Inhibrx, La Jolla, CA, United States
John Timmer
Inhibrx, La Jolla, CA, United States
Brendan Eckelman
Inhibrx, La Jolla, CA, United States
Analeah Heidt
Inhibrx, La Jolla, CA, United States
William Crago
Inhibrx Inc., La Jolla, CA, United States
Emily Rowell
Inhibrx, Inc., La Jolla, CA, USA
Elisabeth Torretti
Inhibrx, Inc., La Jolla, CA, USA
DOI
https://doi.org/10.1136/jitc-2021-SITC2021.856
Journal volume & issue
Vol. 9, no. Suppl 2
Abstract
Read online
No abstracts available.
WeChat QR code
Close